Back to Directory
Insulin Degludec
Performance & EnduranceUltra-long-acting basal insulin with 42-hour duration, marketed as Tresiba.
Key Benefits
- ✓Ultra-long duration (42+ hours)
- ✓Most flexible dosing timing
- ✓Lowest hypoglycemia risk
- ✓Flat basal coverage
- ✓Once-daily
Dosing Information
Dosage Range
Variable
Frequency
Once daily (flexible timing)
Typical Duration
Lifelong
Detailed Protocol
Administered subcutaneously once daily at any time. Can be taken at different times each day due to ultra-long action. Dose adjusted to fasting glucose.
About Insulin Degludec
Insulin degludec (Tresiba) is an ultra-long-acting basal insulin with duration exceeding 42 hours. Forms multi-hexamers subcutaneously creating depot for ultra-long action. Most flexible dosing of basal insulins.
Research Notes
FDA-approved in 2015. Ultra-long half-life allows flexible dosing. Studies show lowest hypoglycemia rates among basal insulins. Premium basal insulin option.
Potential Side Effects
- •Hypoglycemia (lowest risk)
- •Weight gain
- •Injection site reactions
- •Nasopharyngitis
Always consult with a healthcare professional before starting any peptide therapy.